Results

Total Results: 2,116 records

Showing results for "risks".

401. S13 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s13.pdf
     October 01, 2007 - Historically, those who investigate the effects of mar- keted pharmaceuticals have focused on the risk … Finally, in recent years, there has been an increased focus on risk management of drugs (ie, modifi- … Variation in risk can also depend on duration. … Patterns of risk related to last exposure can also vary. … Managing the risks from medical product use: creating a risk management framework. http://www.fda. gov

402. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0129_07-13-2009.pdf
     January 01, 2009 - 10 1 Results of Topic Selection Process & Next Steps  Cesarean birth in low-risk … The nominator is interested in which factors influence the probability of cesarean birth in low-risk … women and which interventions are most effective at reducing the risk of emergency and/or medically … Which interventions are most effective at reducing the risk of needing an emergency and/or medically … Some of the Healthy People 2010 objectives focus on reducing cesarean births among low-risk women.

403. Bladder-Cancer-Non-Muscle-Invasive Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-non-muscle-invasive_research-protocol.pdf
     July 21, 2014 - number of available tests and testing strategies and potential trade- offs in diagnostic accuracy, risks … groups, may be especially useful for patients in the intermediate and high risk groups. … of bias,” “medium risk of bias,” or “high risk of bias.”15, 17 Studies rated “low risk of bias” will … We will not exclude studies rated as being high risk of bias a priori, but high risk of bias studies … Each study evaluated will be independently reviewed for risk of bias by two team members.

404. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
     May 01, 2022 - There may be a large increased risk of dizziness and sedation, and a moderate increased risk of nausea … -point scale • SMD >0.8 • RR/OR ≥2.0 Abbreviations: MD = mean difference; OR = odds ratio; RR = relative … confidence interval; KQ = Key Question; MD = mean difference; RCT = randomized controlled trial; RR = relative … ; KQ = Key Question; MD = mean difference; OR = odds ratio; RCT = randomized controlled trial; RR = relative … General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to

405. Methods Guide for Medical Test Reviews Chapter 7 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
     July 01, 2012 - When the treatment of a disease has high associated risks, multiple tests are often used to assure the … false negatives depends on the severity of disease if there is a missed diagnosis, in addition to the risks … from the testing itself (i.e., if the test is invasive and associated with risks in and of itself). … of bias: • Low risk of bias • Medium risk of bias • High risk of bias Well designed and executed … Assessing risk of bias as a domain of quality in medical test studies.

406. Mental-Illness-Heart Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
     April 01, 2013 - profile among adults with SMI at elevated risk of CVD. … factors in adults with SMI who have elevated risk for CVD. … indices (e.g., Framingham Risk Score). … These guidelines for the general population should then be modified to consider the special risks for … or cardiovascular events Insufficient information Risk indices (e.g., Framingham Risk Score) and

407. Stem-Cell-Children Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
     February 01, 2012 - Ewing’s sarcoma family of tumors, and high-risk relapsed Wilm’s tumor. … The four required domains—risk of bias, consistency, directness, and precision—were considered for … The decision to apply a high-risk procedure such as HSCT to this population is not clear cut. … conditions addressed in this systematic review, evidence is insufficient to draw conclusions as to the relative … risk-benefit ratio of HSCT versus other management approaches.

408. Colon-Cancer-Gene-Profiling Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
     March 13, 2012 - A number of negative prognostic factors (factors associated with increased risk of recurrence) have … Identifying the individuals in whom the potential benefits of chemotherapy outweigh the risks is challenging … T4 tumor) may be inadequate for determining individual risk. … On the other hand, introducing routine testing without a clear understanding of benefits and risks could … obtained with standard risk factors?

409. Technical Brief Disposition of Comments Report for Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colon-cancer-gene-profiling_disposition-comments.pdf
     December 14, 2012 - exists to support the clinical utility of the GEP tests to alter or improve health outcomes and the risks … The 5-year distant-metastasis free survival was 95% for low risk patients and 80% for high risk patients … The 3-year RFS was 91% for Low Risk and 74% for High Risk patients with a HR of 2.9 (p=0.001).” … ColoPrint better distinguishes low and high risk groups as compared to risk assessment using current … ColoPrint better distinguishes low and high risk groups as compared to risk assessment using current

410. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-risk-bias.ppt
     June 01, 2012 - Assessing risk of bias as a domain of quality in medical test studies. … Assessing risk of bias as a domain of quality in medical test studies. … Assessing risk of bias as a domain of quality in medical test studies. … Assessing risk of bias as a domain of quality in medical test studies. … (Risk: Low/High/Unclear) QUADAS-2 Questions for Assessing Risk

411. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-risk-bias.ppt
     June 01, 2012 - Assessing risk of bias as a domain of quality in medical test studies. … Assessing risk of bias as a domain of quality in medical test studies. … Assessing risk of bias as a domain of quality in medical test studies. … Assessing risk of bias as a domain of quality in medical test studies. … (Risk: Low/High/Unclear) QUADAS-2 Questions for Assessing Risk

412. Medication-Therapy-Management Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-therapy-management_executive.pdf
     November 01, 2014 - A broadly defined scope for this review risks including studies that may be too different from each … A narrowly defined scope for this review risks the omission of studies that met the definition of MTM … In other words, we evaluated trials with potential randomization failure for the same risks of bias … therapy management; NA = not applicable; OR = odds ratio; RCT = randomized controlled trial; RRR = relative … risk ratio.

413. bipolar-disorder-treatment-protocol-140623 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/bipolar-disorder-treatment_research-protocol.pdf
     June 23, 2014 - when considering a specific treatment option versus no treatment, they would need to consider the risks … We define a “direct” harm as harm a patient risks by virtue of receiving the treatment and is part of … What can we do to mitigate the side effects of pharmacological treatments that create other medical risks … quality.15 Study-level risk of bias must be assessed using validated risk of bias tools appropriate … Using a random effects model, we will calculate risk ratios (RR) and absolute risk differences (RD)

414. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
     December 01, 2011 - The strength of evidence for higher risks of weight gain with mirtazapine than with other antidepressants … Severe Adverse Events The strength of the evidence on the comparative risks of second-generation antidepressants … trials and observational studies were too small and study durations too short to assess the comparative risks … yield conflicting information about the comparative risk of seizures. … hepatotoxicity about the comparative risk of hepatotoxicity.

415. Postpartum Care for Women Up to One Year After Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
     April 25, 2022 - parenthood, and consider future family planning, but also to mitigate immediate and lifelong health risks … planning and contraception o Adverse pregnancy outcomes associated with cardiometabolic disease o Risks … Assessment of Methodological Risk of Bias of Individual Studies: We will evaluate each study for risk … The three tools will include the Cochrane Risk of Bias Tool,20 the Risk of Bias in Nonrandomized Studies … Severe Maternal Morbidity and Risk of Mortality Beyond the Postpartum Period.

416. Making Healthcare Safer IV_Rapid Response: Use of Report Cards and Outcome Measurements To Improve the Safety of Surgical Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-surgical-report-cards.pdf
     November 01, 2023 - The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment … Using risk-adjusted outcomes to assess clinical practice: an overview of issues pertaining to risk adjustment … The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment … 30-day mortality (relative risk [RR] 0.96, 95% CI, 0.89– 1.03), serious complications (RR 0.96, 95% … Data Bank; O/E = observed vs expected ratio; PDSA = Plan Do Study Act; PE = pulmonary embolism; RR = relative

417. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
     January 30, 2020 - Also, what are the risks of specific adverse events, the frequency of events, and the certainty of the … frequency of potential side effects to help them weigh the benefits of vaccines against potential risks … We will calculate the relative risk for the adverse events for all studies by comparing the intervention … We will summarize the absolute rate of adverse events as well as the relative risk, to facilitate the … Risk analysis : an official publication of the Society for Risk Analysis. 2016;36(7):1297-314. doi:

418. Outcomes in COPD patients treated with theophylline (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
     December 01, 2009 - Mortality risk in chronic obstructive pulmonary disease patients using theophylline. … Compared to similar regimens, patients in regimens that included theophylline had slightly increased risks … these increased risks were generally small (HR of 1.1 to 1.3). … patient-reported outcomes in a real-world setting will be necessary to quantify both the benefits and risks … Inhaled corticosteroids and the risk of a first exacerbation in COPD patients.

419. Outcomes in COPD patients treated with theophylline (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-management_research.pdf
     December 01, 2009 - Mortality risk in chronic obstructive pulmonary disease patients using theophylline. … Compared to similar regimens, patients in regimens that included theophylline had slightly increased risks … these increased risks were generally small (HR of 1.1 to 1.3). … patient-reported outcomes in a real-world setting will be necessary to quantify both the benefits and risks … Inhaled corticosteroids and the risk of a first exacerbation in COPD patients.

420. Methods Guide for Medical Test Reviews Chapter 11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-genetic_methods.pdf
     July 01, 2012 - What health risks can be identified for follow-up testing and/or intervention? 35. … Tests for BRCA mutations may be used to predict the risk for breast and ovarian cancer in high-risk … women (i.e., those with a family history suggesting increased risk). … Lyon, France: IARC Monogr Eval Carcinog Risks Hum; 1999. p. 23-36. 45. … Genetic risk assessment: recommendation statement.